​

Funding Round

Post-IPO Equity - Achillion Pharmaceuticals

Post-IPO Equity - Achillion Pharmaceuticals

Investment Firm

Overview

A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.

Announced Date

Aug 18, 2010

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorClarus Ventures
Participant InvestorPappas Ventures
Participant InvestorQuaker BioVentures
Participant InvestorDomain Associates

Round Details and Background

Achillion Pharmaceuticals raised $50100000 on 2010-08-18 in Post-IPO Equity

A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 22, 2011
Post-IPO Equity - Achillion Pharmaceuticals
-60.9M
Feb 27, 2013
Post-IPO Equity - Achillion Pharmaceuticals
-133.5M
Jan 28, 2002
Venture Round - Achillion Pharmaceuticals
10-41.0M
Aug 18, 2010
Post-IPO Equity - Achillion Pharmaceuticals
4-50.1M

Recent Activity

There is no recent news or activity for this profile.